Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Receivables (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Receivables for 5 consecutive years, with $550000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables rose 1310.26% year-over-year to $550000.0, compared with a TTM value of $550000.0 through Sep 2025, up 1310.26%, and an annual FY2024 reading of $45000.0, changed 0.0% over the prior year.
  • Receivables was $550000.0 for Q3 2025 at Lucid Diagnostics, up from $373000.0 in the prior quarter.
  • Across five years, Receivables topped out at $10.7 million in Q2 2023 and bottomed at $21000.0 in Q3 2023.
  • Average Receivables over 5 years is $2.2 million, with a median of $286500.0 recorded in 2021.
  • The sharpest move saw Receivables soared 3220.5% in 2022, then plummeted 99.68% in 2023.
  • Year by year, Receivables stood at $1.9 million in 2021, then soared by 168.01% to $5.0 million in 2022, then tumbled by 99.1% to $45000.0 in 2023, then changed by 0.0% to $45000.0 in 2024, then surged by 1122.22% to $550000.0 in 2025.
  • Business Quant data shows Receivables for LUCD at $550000.0 in Q3 2025, $373000.0 in Q2 2025, and $61000.0 in Q1 2025.